Puma Biotechnology Inc (PBYI) — Cash Flow Reinvestment Rate
Puma Biotechnology Inc (PBYI) has a Cash Flow Reinvestment Rate of 1.88x as of December 2025, reinvesting $27.05 Million (capex $36.00K plus investments $-27.01 Million) from operating cash flow of $14.42 Million. Explore Puma Biotechnology Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Puma Biotechnology Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Puma Biotechnology Inc across 6 annual periods. Also explore balance sheet size of Puma Biotechnology Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Puma Biotechnology Inc (2019–2025)
Year-by-year capital reinvestment analysis for Puma Biotechnology Inc. For live market cap and broader valuation context, see Puma Biotechnology Inc (PBYI) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.87x | $36.19 Million | $41.80 Million | $71.00K | ▲ +64.4% |
| 2024 | 0.53x | $20.49 Million | $38.92 Million | $56.00K | ▼ -59.9% |
| 2023 | 1.31x | $35.47 Million | $27.01 Million | $12.64 Million | ▲ +149.2% |
| 2021 | 0.53x | $10.88 Million | $20.65 Million | $1.00K | ▼ -99.3% |
| 2020 | 79.37x | $63.49 Million | $800.00K | $20.05 Million | ▲ +30652.5% |
| 2019 | 0.26x | $5.78 Million | $22.38 Million | $306.00K | — |